GT MOLECULAR, INC: public contracts won without a rival in United States

Updated 17 October 2026 · 2023-12-29 to 2024-09-03 · all of United States

GT MOLECULAR, INC: public contracts won without a rival in United States: 2 uncontested awards; 100% of its awards; 1 without a competition; 1 single bid.

Assay record ASY-US-0INE3Z419N · Cite as: Assay Systems, “GT MOLECULAR, INC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/gt-molecular-inc/

1
2uncontested awards
100%of its awards
1without a competition
1single bid

GT MOLECULAR, INC won 2 of its 2 public contract awards in United States without a rival from 2023-12-29 to 2024-09-03, worth $1.1M: 1 without a competition and 1 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Centers for Disease Control and Prevention with 2.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

Centers for Disease Control and Prevention2uncontested2awards$1.1Mvalue

Centers for Disease Control and Prevention gave GT MOLECULAR, INC 2 awards: 1 without a competition, 1 after a competition with a single bid. First 2023-12-29, latest 2024-09-03.

Latest awards without a rival

DateBuyerHowValueStated reason
2024-09-03Centers for Disease Control and Prevention
75D30124C19209
Single bid
COMPETED UNDER SAP
$1.0M—
2023-12-29Centers for Disease Control and Prevention
75D30122P15161
No competition
NOT COMPETED UNDER SAP
$49.5KSAP NON-COMPETITION (FAR 13)

Every uncontested award in United States · All countries

Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.